Screening of novel inhibitors of HIV-1 reverse transcriptase with a reporter ribozyme assay

Methods in Molecular Biology

Volumn 535, Issue , 2009, Pages 187-199

  Yamazaki, Satoko ^a   Famulok, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

allosteric ribozyme; aptamer; FRET; HIV 1 RT; HTS; reporter ribozyme

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APTAMER; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RIBOZYME; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ALLOSTERISM; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; ENZYMOLOGY; EVALUATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOLECULAR LIBRARY;

ALLOSTERIC REGULATION; ANTI-HIV AGENTS; APTAMERS, NUCLEOTIDE; DRUG DESIGN; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; REVERSE TRANSCRIPTASE INHIBITORS; RNA, CATALYTIC; SMALL MOLECULE LIBRARIES;

EID: 79958263401     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-557-2_11     Document Type: Article

References (14)

1. Hartig, J.S. and Famulok, M. (2002) Reporter ribozymes for real-time analysis of domain-specific interactions in biomole-cules: HIV-1 reverse transcriptase and the primer-template complex. Angew. Chem. Int. Ed. Engl. 41, 4263-4266. (Pubitemid 35398248)
2. Tuerk, C., MacDougal, S. and Gold, L. (1992) RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase Proc. Natl. Acad. Sci. U.S.A. 89, 6988-6992.
3. Jaeger, J., Restle, T. and Steitz, T.A. (1998) The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. EMBO J. 17, 4535-4542. (Pubitemid 28362641)
4. Chaloin, L., Lehmann, M.J., Sczakiel, G. and Restle, T. (2002) Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. Nucleic Acids Res. 30, 4001-4008.
5. Joshi, P. and Prasad, V.R. (2002) Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse tran-scriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). J. Virol. 76, 6545-6557. (Pubitemid 34633520)
6. Jonckheere, H., Anne, J. and De Clercq, E. (2000) The HIV-1 reverse transcription (RT) process as target for RT inhibitors. Med. Res. Rev. 20, 129-154. (Pubitemid 30134322)
7. Menendez-Arias, L. (2002) Targeting HIV: antiretroviral therapy and development of drug resistance Trends Pharmacol. Sci. 23, 381-388.
8. Imamichi, T. (2004) Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors. Curr. Pharm. Des. 10, 4039-4053. (Pubitemid 39654466)
9. Joshi, P.J., Fisher, T.S. and Prasad, V.R. (2003) Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent anti-virals. Curr. Drug Targets Infect. Disord. 3, 383-400. (Pubitemid 38016625)
10. Ng, E.W., Shima, D.T., Calias, P., Cunningham, E.T., Jr., Guyer, D.R. and Adamis, A.P. (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease Nat. Rev. Drug Discov. 5, 123-132.
11. Hartig, J.S., Najafi-Shoushtari, S.H., Grüne, I., Yan, A., Ellington, A.D. and Famulok, M. (2002) Protein-dependent ribozymes report molecular interactions in real time. Nat. Bio-technol. 20, 717-722. (Pubitemid 34734139)
12. Yamazaki, S., Tan, L., Mayer, G., Hartig, J.S., Song, J.N., Reuter, S., Restle, T., Lau-fer, S.D., Grohmann, D., Kräusslich, H.G., Bajorath, J. and Famulok, M. (2007) Apta-mer displacement identifies alternative small-molecule target sites that escape viral resistance. Chem. Biol. 14, 804-812. (Pubitemid 47081421)
13. Nimjee, S.M., Rusconi, C.P. and Sullenger, B.A. (2005) Aptamers: an emerging class of therapeutics. Annu. Rev. Med. 56, 555-583. (Pubitemid 40299797)
14. Que-Gewirth, N.S. and Sullenger, B.A. (2007) Gene therapy progress and prospects: RNA aptamers. Gene Ther. 14, 283-291. (Pubitemid 46231922)